Neil Herskowitz, director at Mustang Bio, Inc. ($MBIO), made one open market sale of common shares in the last year, totaling $238. His most recent $MBIO insider sale occurred on December 30, 2025. Among 11,678 insiders with open market sales, his activity ranks 11,585th by amount, well below the average of $8.6 million across 6.4 transactions. Herskowitz had no open market purchases in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 30, 2025 | MUSTANG BIO, INC. | $MBIO | Herskowitz Neil | Director | S | COMMON STOCK, PAR VALUE $0.0001 | 247 | $0.96 | 145.0000 | 6,241,658 | 63.01% | 0.00% |
| Aug. 5, 2025 | Journey Medical Corp | $DERM | Herskowitz Neil | Director | A | Common Stock, $0.0001 par value | 20000 | $0.00 | 108,618.0000 | 23,290,806 | 22.57% | 0.09% |
| June 25, 2025 | Journey Medical Corp | $DERM | Herskowitz Neil | Director | A | Common Stock, $0.0001 par value | 7173 | $0.00 | 88,618.0000 | 22,611,040 | 8.81% | 0.03% |
| Dec. 2, 2024 | AVENUE THERAPEUTICS, INC. | $ATXI | Herskowitz Neil | Director | S | COMMON STOCK, PAR VALUE $0.0001 | 23 | $2.00 | 97.0000 | 341,324 | 19.17% | 0.01% |
| Sept. 23, 2024 | AVENUE THERAPEUTICS, INC. | $ATXI | Herskowitz Neil | Director | A | Employee stock option (right to buy) | 30000 | $0.00 | 30,000.0000 | 341,324 | 9999.99% | 8.79% |
| July 8, 2024 | Journey Medical Corp | $DERM | Herskowitz Neil | Director | A | Common Stock, $0.0001 par value | 9728 | $0.00 | 81,445.0000 | 19,993,858 | 13.56% | 0.05% |
| June 30, 2023 | AVENUE THERAPEUTICS, INC. | $ATXI | Herskowitz Neil | Director | A | Employee stock option (right to buy) | 100000 | $0.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |